Szczepionka BCG (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Szczepionka BCG" in Polish language version.

refsWebsite

Global rank Polish rank

12nih.gov

4^th place

7^th place

10doi.org

2^nd place

6^th place

8worldcat.org

5^th place

2^nd place

3who.int

195^th place

256^th place

1pzh.gov.pl

low place

1,053^rd place

1sciencedirect.com

149^th place

235^th place

1thelancet.com

2,393^rd place

1,131^st place

1dailymail.co.uk

219^th place

80^th place

dailymail.co.uk

Human trials to begin on 'diabetes cure' after terminally ill mice are returned to health | Mail Online

doi.org

dx.doi.org

NiyatiN. Lobo NiyatiN. i inni, 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19, „Nature Reviews. Urology”, 18 (10), 2021, s. 611–622, DOI: 10.1038/s41585-021-00481-1, ISSN 1759-4820, PMID: 34131332, PMCID: PMC8204595 [dostęp 2022-09-01] .
Paul K.P.K. Hegarty Paul K.P.K. i inni, COVID-19 and Bacillus Calmette-Guérin: What is the Link?, „European Urology Oncology”, 3 (3), 2020, s. 259–261, DOI: 10.1016/j.euo.2020.04.001, ISSN 2588-9311, PMID: 32327396, PMCID: PMC7152883 [dostęp 2020-10-09] .
MatteoM. Riccò MatteoM. i inni, Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)., „Acta Bio Medica Atenei Parmensis”, 91 (2), 2020, s. 207–213, DOI: 10.23750/abm.v91i2.9700, PMID: 32420947, PMCID: PMC7569626 [dostęp 2022-09-01] .
YusukeY. Tomita YusukeY. i inni, BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis, „Vaccine”, 38 (41), 2020, s. 6352–6356, DOI: 10.1016/j.vaccine.2020.08.045, ISSN 0264-410X, PMID: 32863070, PMCID: PMC7440160 [dostęp 2022-09-01] (ang.).
SanjaS. Glisic SanjaS. i inni, Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2, „Journal of Proteome Research”, 19 (11), 2020, s. 4649–4654, DOI: 10.1021/acs.jproteome.0c00410, ISSN 1535-3907, PMID: 32794723 [dostęp 2022-09-01] .
NadiaN. Rahali NadiaN., ChokriCh. Bahloul ChokriCh., Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model, „Current Microbiology”, 79 (9), 2022, s. 275, DOI: 10.1007/s00284-022-02971-w, ISSN 1432-0991, PMID: 35907089, PMCID: PMC9362411 [dostęp 2022-09-01] .
Judith R.J.R. Glynn Judith R.J.R. i inni, The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi, „The Lancet Infectious Diseases”, 21 (11), 2021, s. 1590–1597, DOI: 10.1016/S1473-3099(20)30994-4, ISSN 1473-3099, PMID: 34237262, PMCID: PMC8550897 [dostęp 2022-09-01] (ang.).
MasayukiM. Miyasaka MasayukiM., Is BCG vaccination causally related to reduced COVID-19 mortality?, „EMBO molecular medicine”, 12 (6), 2020, e12661, DOI: 10.15252/emmm.202012661, ISSN 1757-4684, PMID: 32379923, PMCID: PMC7267326 [dostęp 2022-09-01] .

doi.org

Black GF., Weir RE., Floyd S., Bliss L., Warndorff DK., Crampin AC., Ngwira B., Sichali L., Nazareth B., Blackwell JM., Branson K., Chaguluka SD., Donovan L., Jarman E., King E., Fine PE., Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.. „Lancet”. Apr 20;359. 9315, s. 1393-401, 2002. DOI: 10.1016/S0140-6736(02)08353-8. PMID: 11978337.
Mosolits S., Nilsson B., Mellstedt H. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.. „Expert Rev Vaccines”. Jun;4. 3, s. 329-50, 2005. DOI: 10.1586/14760584.4.3.329. PMID: 16026248.

nih.gov

ncbi.nlm.nih.gov

SimonaS. Luca SimonaS., TraianT. Mihaescu TraianT., History of BCG Vaccine, „Maedica”, 8 (1), 2013, s. 53–58, ISSN 1841-9038, PMID: 24023600, PMCID: PMC3749764 [dostęp 2022-09-01] .
NiyatiN. Lobo NiyatiN. i inni, 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19, „Nature Reviews. Urology”, 18 (10), 2021, s. 611–622, DOI: 10.1038/s41585-021-00481-1, ISSN 1759-4820, PMID: 34131332, PMCID: PMC8204595 [dostęp 2022-09-01] .
Black GF., Weir RE., Floyd S., Bliss L., Warndorff DK., Crampin AC., Ngwira B., Sichali L., Nazareth B., Blackwell JM., Branson K., Chaguluka SD., Donovan L., Jarman E., King E., Fine PE., Dockrell HM. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.. „Lancet”. Apr 20;359. 9315, s. 1393-401, 2002. DOI: 10.1016/S0140-6736(02)08353-8. PMID: 11978337.
Paul K.P.K. Hegarty Paul K.P.K. i inni, COVID-19 and Bacillus Calmette-Guérin: What is the Link?, „European Urology Oncology”, 3 (3), 2020, s. 259–261, DOI: 10.1016/j.euo.2020.04.001, ISSN 2588-9311, PMID: 32327396, PMCID: PMC7152883 [dostęp 2020-10-09] .
MatteoM. Riccò MatteoM. i inni, Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now)., „Acta Bio Medica Atenei Parmensis”, 91 (2), 2020, s. 207–213, DOI: 10.23750/abm.v91i2.9700, PMID: 32420947, PMCID: PMC7569626 [dostęp 2022-09-01] .
YusukeY. Tomita YusukeY. i inni, BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis, „Vaccine”, 38 (41), 2020, s. 6352–6356, DOI: 10.1016/j.vaccine.2020.08.045, ISSN 0264-410X, PMID: 32863070, PMCID: PMC7440160 [dostęp 2022-09-01] (ang.).
SanjaS. Glisic SanjaS. i inni, Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2, „Journal of Proteome Research”, 19 (11), 2020, s. 4649–4654, DOI: 10.1021/acs.jproteome.0c00410, ISSN 1535-3907, PMID: 32794723 [dostęp 2022-09-01] .
NadiaN. Rahali NadiaN., ChokriCh. Bahloul ChokriCh., Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model, „Current Microbiology”, 79 (9), 2022, s. 275, DOI: 10.1007/s00284-022-02971-w, ISSN 1432-0991, PMID: 35907089, PMCID: PMC9362411 [dostęp 2022-09-01] .
Judith R.J.R. Glynn Judith R.J.R. i inni, The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi, „The Lancet Infectious Diseases”, 21 (11), 2021, s. 1590–1597, DOI: 10.1016/S1473-3099(20)30994-4, ISSN 1473-3099, PMID: 34237262, PMCID: PMC8550897 [dostęp 2022-09-01] (ang.).
MasayukiM. Miyasaka MasayukiM., Is BCG vaccination causally related to reduced COVID-19 mortality?, „EMBO molecular medicine”, 12 (6), 2020, e12661, DOI: 10.15252/emmm.202012661, ISSN 1757-4684, PMID: 32379923, PMCID: PMC7267326 [dostęp 2022-09-01] .
Lamm DL., Blumenstein BA., Crawford ED., Montie JE., Scardino P., Grossman HB., Stanisic TH., Smith JA., Sullivan J., Sarosdy MF. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.. „N Engl J Med”. Oct 24;325. 17, s. 1205-9, 1991. PMID: 1922207.
Mosolits S., Nilsson B., Mellstedt H. Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials.. „Expert Rev Vaccines”. Jun;4. 3, s. 329-50, 2005. DOI: 10.1586/14760584.4.3.329. PMID: 16026248.

pzh.gov.pl

szczepienia.pzh.gov.pl

ZygmuntZ. Moskwa ZygmuntZ., Historia szczepień przeciwgruźliczych i powstanie szczepionki BCG, „Wiadomości Lekarskie”, 36 (1), 1983, s. 81-85 (pol.).

sciencedirect.com

YusukeY. Tomita YusukeY. i inni, BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis, „Vaccine”, 38 (41), 2020, s. 6352–6356, DOI: 10.1016/j.vaccine.2020.08.045, ISSN 0264-410X, PMID: 32863070, PMCID: PMC7440160 [dostęp 2022-09-01] (ang.).

thelancet.com

Judith R.J.R. Glynn Judith R.J.R. i inni, The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi, „The Lancet Infectious Diseases”, 21 (11), 2021, s. 1590–1597, DOI: 10.1016/S1473-3099(20)30994-4, ISSN 1473-3099, PMID: 34237262, PMCID: PMC8550897 [dostęp 2022-09-01] (ang.).

who.int

apps.who.int

World HealthW.H. Organization World HealthW.H., BCG vaccines: WHO position paper – February 2018, „Weekly Epidemiological Record”, 93 (08), 23 lutego 2018, s. 73–96 [dostęp 2021-01-03] (ang.).
World HealthW.H. Organization World HealthW.H., World Health Organization model list of essential medicines: 21st list 2019 [online], 2019 [dostęp 2021-01-03] (ang.).

who.int

World Health Organization, Weekly epidemiological record, 2004

worldcat.org

SimonaS. Luca SimonaS., TraianT. Mihaescu TraianT., History of BCG Vaccine, „Maedica”, 8 (1), 2013, s. 53–58, ISSN 1841-9038, PMID: 24023600, PMCID: PMC3749764 [dostęp 2022-09-01] .
NiyatiN. Lobo NiyatiN. i inni, 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19, „Nature Reviews. Urology”, 18 (10), 2021, s. 611–622, DOI: 10.1038/s41585-021-00481-1, ISSN 1759-4820, PMID: 34131332, PMCID: PMC8204595 [dostęp 2022-09-01] .
Paul K.P.K. Hegarty Paul K.P.K. i inni, COVID-19 and Bacillus Calmette-Guérin: What is the Link?, „European Urology Oncology”, 3 (3), 2020, s. 259–261, DOI: 10.1016/j.euo.2020.04.001, ISSN 2588-9311, PMID: 32327396, PMCID: PMC7152883 [dostęp 2020-10-09] .
YusukeY. Tomita YusukeY. i inni, BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis, „Vaccine”, 38 (41), 2020, s. 6352–6356, DOI: 10.1016/j.vaccine.2020.08.045, ISSN 0264-410X, PMID: 32863070, PMCID: PMC7440160 [dostęp 2022-09-01] (ang.).
SanjaS. Glisic SanjaS. i inni, Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2, „Journal of Proteome Research”, 19 (11), 2020, s. 4649–4654, DOI: 10.1021/acs.jproteome.0c00410, ISSN 1535-3907, PMID: 32794723 [dostęp 2022-09-01] .
NadiaN. Rahali NadiaN., ChokriCh. Bahloul ChokriCh., Induction of Cross-Reacting Antibodies Against the COVID-19 by BCG Vaccination in the Mouse Model, „Current Microbiology”, 79 (9), 2022, s. 275, DOI: 10.1007/s00284-022-02971-w, ISSN 1432-0991, PMID: 35907089, PMCID: PMC9362411 [dostęp 2022-09-01] .
Judith R.J.R. Glynn Judith R.J.R. i inni, The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi, „The Lancet Infectious Diseases”, 21 (11), 2021, s. 1590–1597, DOI: 10.1016/S1473-3099(20)30994-4, ISSN 1473-3099, PMID: 34237262, PMCID: PMC8550897 [dostęp 2022-09-01] (ang.).
MasayukiM. Miyasaka MasayukiM., Is BCG vaccination causally related to reduced COVID-19 mortality?, „EMBO molecular medicine”, 12 (6), 2020, e12661, DOI: 10.15252/emmm.202012661, ISSN 1757-4684, PMID: 32379923, PMCID: PMC7267326 [dostęp 2022-09-01] .